Members of the BrainGate research team are affiliated with Brown University, Massachusetts General Hospital, Stanford University, Case Western Reserve University and Providence VA Medical Center. BrainGate creates and tests micro-electrodes implanted into the brain which are able to decode neural signals associated with the intent to move a limb in real-time and use that information to operate external devices.
An investigative device called BrainGate Neural Interface System was developed from preclinical research at Brown University. The BrainGate Consortia is conducting clinical trials for the BrainGate2 Neural Interface System. BrainGate2 is an intracortical neural interface system in clinical trials for use in persons with tetraplegia to control a computer cursor and other assistive devices with their thoughts. BrainGate Co. is a privately-held firm which holds the core intellectual property for the BrainGate system and is focused on advancing the BrainGate Neural Interface System.
